elements
-live
Search elements, keywords, and sectors
🔎
Elements
Subjects
Pricing
Log in
Sign up
Home
/
Subjects
/
Antagonist
← Back to subjects
Current data, viewed at
Yearly
resolution.
Personal members see monthly resolution →
Keyword
keyword
Antagonist
RIS
0.001
(Research Intensity Score)
Papers
74
Top papers
Sodium-Glucose Cotransporter 2 Inhibitor With and Without an Aldosterone Antagonist for Heart Failure With Preserved Ejection Fraction
2025 · 21 citations
First-in-human administration of terbium-161-labelled somatostatin receptor subtype 2 antagonist ([161Tb]Tb-DOTA-LM3) in a patient with a metastatic neuroendocrine tumour of the ileum
2024 · 43 citations
Fluorine-containing drugs approved by the FDA in 2019
2020 · 223 citations
A true theranostic pair – 44/47Sc-labeled GRPR antagonist shows great promise for managing prostate and breast cancer
2025 · 5 citations
Cardiac Conduction Delay for Sodium Channel Antagonist Antiseizure Medications
2025 · 8 citations
Thirty-six months in vivo wear of enamel antagonists to monolithic zirconia crowns
2026
Distinct brain regions mediate regulation of food intake in response to GIPR agonism or antagonism
2026
Strychnine poisoning in children
2026
Investigation of reported small molecule P2Y6 receptor antagonists
2026
Newest papers
Thirty-six months in vivo wear of enamel antagonists to monolithic zirconia crowns
2026
Distinct brain regions mediate regulation of food intake in response to GIPR agonism or antagonism
2026
Strychnine poisoning in children
2026
Investigation of reported small molecule P2Y6 receptor antagonists
2026
TRPV4: A Promising Therapeutic Target Ion Channel─Discovery of Ultrapotent Selective Antagonists
2026
Formulation and Evaluation of Mouth Dissolving Tablet Containing Aprepitant for Chemotherapy Induced Nausea and Vomiting
2026
Direct Androgen Receptor Antagonism Enhances Therapeutic PSMA Radioligand Uptake in Prostate Cancer Models
2026
Bioisostere-Driven Discovery of SePP: A Selenium-Containing Polypharmacological Agent Relevant to Fragile X Syndrome
2026 · 1 citations
Alpha Therapy Beyond TOC and TATE—Production, Quality Control, and In-Human Results for the SSTR2 Antagonist DOTA-LM3
2026 · 1 citations
Browse all papers →
Antagonist's history
Research intensity over time
Yearly
Personal members see monthly resolution →
Data temporarily unavailable — please try again shortly.
Close ✕
Antagonist's papers
Ordered by current research-activity contribution.
Loading…
Close ✕
Read full text ↗
Share
Share on X
Share on Facebook
Share on LinkedIn
Copy link